Annie Martin, Global Head of Presicion Medicine, has discussed the future of targeted therapy and genomic profiling, describing how to profile tumors with RNA and DNA sequencing.
Source: Novartis
Future of targeted therapy and genomic profiling
Meet Annie Martin, Global Head of Presicion Medicine, Novartis